Personalized Disease Screening Decisions Considering a Chronic Condition

References

• AA (2019) Alzheimer’s Association facts and figures. Accessed March 10, 2019, https://www.alz.org/alzheimers-dementia/facts-figures.Google Scholar
• Ackermann RT, Cheng YJ, Williamson DF, Gregg EW (2011) Identifying adults at high risk for diabetes and cardiovascular disease using hemoglobin A1c. Amer. J. Preventative Medicine 40(1):11–17.Crossref, Google Scholar
• ACS (2015) Cancer facts & figures 2015. Technical report, American Cancer Society, Atlanta, GA.Google Scholar
• ACS (2018) American Cancer Society guidelines for the early detection of cancer. Accessed September 23, 2018, https://www.cancer.org/healthy/find-cancer-early/american-cancer-society-guidelines-for-the-early-detection-of-cancer.html.Google Scholar
• ACS (2019a) Cancer A-Z. Accessed March 10, 2019, https://www.cancer.org/cancer/.Google Scholar
• ACS (2019b) Treatment of breast cancer by stage. Accessed April 4, 2019, https://www.cancer.org/cancer/breast-cancer/treatment/treatment-of-breast-cancer-by-stage.html.Google Scholar
• ADA (2016) Diagnosing diabetes and learning about prediabetes. Accessed November 17, 2017, https://www.diabetes.org/diabetes/a1c/diagnosis.Google Scholar
• AHA (2017) Heart disease and stroke statistics 2017. Accessed October 21, 2018, https://www.heart.org/.Google Scholar
• Ahmadieh H, Azar ST (2013) Type 2 diabetes mellitus, oral diabetic medications, insulin therapy, and overall breast cancer risk. ISRN Endocrinology 2013(2013):181240.Google Scholar
• ALA (2018) Lung cancer fact sheet. Accessed October 21, 2018, https://www.lung.org/lung-health-diseases/lung-disease-lookup/lung-cancer/resource-library/lung-cancer-fact-sheet.Google Scholar
• Alagoz O, Ayer T, Erenay FS (2011) Operations research models for cancer screening. J.J. Cochran, L.A. Cox, P. Keskinocak, J.P. Kharoufeh, J.C. Smith, eds. Wiley Encyclopedia of Operations Research and Management Science (John Wiley & Sons, Hoboken, NJ), 1–14.Crossref, Google Scholar
• Alagoz O, Ergun MA, Cevik M, Sprague BL, Fryback DG, Gangnon RE, Hampton JM, Stout NK, Trentham-Dietz A (2018a) The University of Wisconsin breast cancer epidemiology simulation model: An update. Medical Decision Making 38(1 suppl):99S–111S.Crossref, Google Scholar
• Alagoz O, Berry DA, de Koning HJ, Feuer EJ, Lee SJ, Plevritis SK, Schechter CB, Stout NK, Trentham-Dietz A, Mandelblatt JS (2018b) Introduction to the Cancer Intervention and Surveillance Modeling Network (CISNET) breast cancer models. Medical Decision Making 38(1 suppl):3S–8S.Crossref, Google Scholar
• Arias E, Heron MP, Xu J (2017) United States life tables, 2014. Technical report, U.S. Department of Health and Human Services, Washington, DC.Google Scholar
• Ashley EA (2015) The precision medicine initiative: A new national effort. JAMA 313(21):2119–2120.Crossref, Google Scholar
• Ayer T, Alagoz O, Stout NK (2012) OR Forum: A POMDP approach to personalize mammography screening decisions. Oper. Res. 60(5):1019–1034.Link, Google Scholar
• Ayer T, Alagoz O, Stout NK, Burnside ES (2015) Heterogeneity in women’s adherence and its role in optimal breast cancer screening policies. Management Sci. 62(5):1339–1362.Link, Google Scholar
• Barton MB, Harris R, Fletcher SW (1999) Does this patient have breast cancer? The screening clinical breast examination: Should it be done? How? JAMA 282(13):1270–1280.Crossref, Google Scholar
• Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JDF, Feuer EJ (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. New England J. Medicine 353(17):1784–1792.Crossref, Google Scholar
• Bertoni AG, Krop JS, Anderson GF, Brancati FL (2002) Diabetes-related morbidity and mortality in a national sample of US elders. Diabetes Care 25(3):471–475.Crossref, Google Scholar
• Bertram M, Lim S, Barendregt J, Vos T (2010) Assessing the cost-effectiveness of drug and lifestyle intervention following opportunistic screening for pre-diabetes in primary care. Diabetologia 53(5):875–881.Crossref, Google Scholar
• Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, García FA, Gillman MW, et al. (2016) Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA 315(23):2564–2575.Crossref, Google Scholar
• Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW (2005) Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: Implications for pay for performance. JAMA 294(6):716–724.Crossref, Google Scholar
• Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF (2010) Projection of the year 2050 burden of diabetes in the US adult population: Dynamic modeling of incidence, mortality, and prediabetes prevalence. Population Health Metrics 8(1):29.Crossref, Google Scholar
• Boyle P, Boniol M, Koechlin A, Robertson C, Valentini F, Coppens K, Fairley L-L, et al. (2012) Diabetes and breast cancer risk: A meta-analysis. British J. Cancer 107(9):1608–1617.Crossref, Google Scholar
• Braithwaite RS, Concato J, Chang CC, Roberts MS, Justice AC (2007) A framework for tailoring clinical guidelines to comorbidity at the point of care. Arch. Internal Medicine 167(21):2361–2365.Crossref, Google Scholar
• Buttorff C, Ruder T, Bauman M (2017) Multiple chronic conditions in the United States. Technical report, RAND Corporation, Santa Monica, CA.Google Scholar
• Cao X, Wu Y, Wang J, Liu K, Wang X (2017) The effect of metformin on mortality among diabetic cancer patients: A systematic review and meta-analysis. JNCI Cancer Spectrum 1(1):pkx007.Crossref, Google Scholar
• CDC (2017) National diabetes statistics report. Technical report, Centers for Disease Control and Prevention, Washington, DC.Google Scholar
• CDC (2018) The surprising truth about prediabetes. Accessed April 4, 2019, https://www.cdc.gov/diabetes/library/features/truth-about-prediabetes.html.Google Scholar
• CDC (2019) Diseases & conditions. Accessed March 10, 2019, https://www.cdc.gov/diseasesconditions/index.html.Google Scholar
• Cevik M, Ayer T, Alagoz O, Sprague BL (2018) Analysis of mammography screening policies under resource constraints. Production Oper. Management 27(5):949–972.Crossref, Google Scholar
• Chen Q, Ayer T, Chhatwal J (2018) Optimal M-switch surveillance policies for liver cancer in a hepatitis C–infected population. Oper. Res. 66(3):673–696.Link, Google Scholar
• Chlebowski RT, McTiernan A, Wactawski-Wende J, Manson JE, Aragaki AK, Rohan T, Ipp E, et al. (2012) Diabetes, metformin, and breast cancer in postmenopausal women. J. Clinical Oncology 30(23):2844–2852.Crossref, Google Scholar
• Col NF, Ochs L, Springmann V, Aragaki AK, Chlebowski RT (2012) Metformin and breast cancer risk: A meta-analysis and critical literature review. Breast Cancer Res. Treatment 135(3):639–646.Crossref, Google Scholar
• Costantino JP, Gail MH, Pee D, Anderson S, Redmond CK, Benichou J, Wieand HS (1999) Validation studies for models projecting the risk of invasive and total breast cancer incidence. J. Natl. Cancer Inst. 91(18):1541–1548.Crossref, Google Scholar
• DPPRG (2002) Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England J. Medicine 346(6):393–403.Crossref, Google Scholar
• Duricova D, Pedersen N, Elkjaer M, Gamborg M, Munkholm P, Jess T (2009) Overall and cause-specific mortality in crohn’s disease: A meta-analysis of population-based studies. Inflammatory Bowel Disease 16(2):347–353.Crossref, Google Scholar
• Eagle JN (1984) The optimal search for a moving target when the search path is constrained. Oper. Res. 32(5):1107–1115.Link, Google Scholar
• Earle C, Chapman R, Baker C, Bell C, Stone P, Sandberg E, Neumann P (2000) Systematic overview of cost-utility assessments in oncology. J. Clinical Oncology 18(18):3302–3317.Crossref, Google Scholar
• Edwards BK, Noone AM, Mariotto AB, Simard EP, Boscoe FP, Henley SJ, Jemal A, et al. (2014) Annual report to the nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer 120(9):1290–1314.Crossref, Google Scholar
• Erenay FS, Alagoz O, Said A (2014) Optimizing colonoscopy screening for colorectal cancer prevention and surveillance. Manufacturing Service Oper. Management 16(3):381–400.Link, Google Scholar
• Fleming ST, Pursley HG, Newman B, Pavlov D, Chen K (2005) Comorbidity as a predictor of stage of illness for patients with breast cancer. Medical Care 43(2):132–140.Crossref, Google Scholar
• Flossmann E, Rothwell PM, British Doctors Aspirin Trial and the UK-TIA Aspirin Trial et al.(2007) Effect of aspirin on long-term risk of colorectal cancer: Consistent evidence from randomised and observational studies. Lancet 369(9573):1603–1613.Crossref, Google Scholar
• Foxman B (2002) Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs. Amer. J. Medicine 113(1):5–13.Crossref, Google Scholar
• Gail MH, Costantino JP, Bryant J, Croyle R, Freedman L, Helzlsouer K, Vogel V (1999) Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J. Natl. Cancer Inst. 91(21):1829–1846.Crossref, Google Scholar
• Gallagher EJ, LeRoith D (2010) The proliferating role of insulin and insulin-like growth factors in cancer. Trends Endocrinology Metabolism 21(10):610–618.Crossref, Google Scholar
• García-Esquinas E, Guinó E, Castano-Vinyals G, Pérez-Gómez B, Llorca J, Altzibar JM, Peiró-Pérez R, et al. (2016) Association of diabetes and diabetes treatment with incidence of breast cancer. Acta Diabetologica 53(1):99–107.Crossref, Google Scholar
• Gerteis J, Izrael D, Deitz D, LeRoy L, Ricciardi R, Miller T, Basu J (2014) Multiple chronic conditions chartbook. Technical report, Agency for Healthcare Research and Quality, Cambridge, MA.Google Scholar
• Gonzalez EC, Ferrante JM, Van Durme DJ, Pal N, Roetzheim RG (2001) Comorbid illness and the early detection of cancer. Southern Medical J. 94(9):913–920.Crossref, Google Scholar
• Goodarzi SH, McKenzie K, Nataraj N, Ivy JS, Mayorga M, Mason J, Tejada J (2014) A framework for modeling the complex interaction between breast cancer and diabetes. Proc. 2014 Winter Simulation Conf. (IEEE Press, Savannah, GA), 1245–1256.Google Scholar
• Gray AM, Clarke PM, Wolstenholme JL, Wordsworth S (2011) Applied Methods of Cost-Effectiveness Analysis in Healthcare (Oxford University Press, Oxford, UK). Google Scholar
• Gregg EW, Zhuo X, Cheng YJ, Albright AL, Narayan KV, Thompson TJ (2014) Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985–2011: A modelling study. Lancet Diabetes Endocrinology 2(11):867–874.Crossref, Google Scholar
• Gu K, Cowie CC, Harris MI (1998) Mortality in adults with and without diabetes in a national cohort of the US population, 1971–1993. Diabetes Care 21(7):1138–1145.Crossref, Google Scholar
• Gucciardi E, Wang SC-T, DeMelo M, Amaral L, Stewart DE (2008) Characteristics of men and women with diabetes: Observations during patients’ initial visit to a diabetes education centre. Canadian Family Physician 54(2):219–227.Google Scholar
• Hanmer J, Lawrence WF, Anderson JP, Kaplan RM, Fryback DG (2006) Report of nationally representative values for the noninstitutionalized US adult population for 7 health-related quality-of-life scores. Medical Decision Making 26(4):391–400.Crossref, Google Scholar
• Hardefeldt PJ, Edirimanne S, Eslick GD (2012) Diabetes increases the risk of breast cancer: A meta-analysis. Endocrine-Related Cancer 19(6):793–803.Crossref, Google Scholar
• Hatoum D, McGowan EM (2015) Recent advances in the use of metformin: Can treating diabetes prevent breast cancer? BioMed Res. Internat. 2015(2015):548436.Google Scholar
• HHS (2010) Multiple chronic conditions—a strategic framework: Optimum health and quality of life for individuals with multiple chronic conditions. Technical report, U.S. Department of Health and Human Services, Washington, DC.Google Scholar
• HHS (2016) The challenge of managing multiple chronic conditions. Accessed September 14, 2018, https://www.hhs.gov/ash/about-ash/multiple-chronic-conditions/about-mcc/the-challenge-of-managing-multiple-chronic-conditions/index.html.Google Scholar
• Huang Y, Cai X, Chen P, Mai W, Tang H, Huang Y, Hu Y (2014) Associations of prediabetes with all-cause and cardiovascular mortality: A meta-analysis. Ann. Medicine 46(8):684–692.Crossref, Google Scholar
• IOF (2011) Facts and statistics. Accessed October 21, 2018, https://www.osteoporosis.foundation/facts-statistics.Google Scholar
• Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England J. Medicine 346(6):393–403.Crossref, Google Scholar
• Koczwara B (2016) Cancer and Chronic Conditions: Addressing the Problem of Multimorbidity in Cancer Patients and Survivors (Springer, Bedford Park, Australia).Crossref, Google Scholar
• Kuo C-C, Yeh H-C, Chen B, Tsai C-W, Lin Y-S, Huang C-C (2015) Prevalence of metformin use and the associated risk of metabolic acidosis in us diabetic adults with CKD: A national cross-sectional study. Medicine (Baltimore) 94(51):e2175.Crossref, Google Scholar
• Larsson SC, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of breast cancer: A meta-analysis. Internat. J. Cancer 121(4):856–862.Crossref, Google Scholar
• Leach CR, Klabunde CN, Alfano CM, Smith JL, Rowland JH (2012) Physician over-recommendation of mammography for terminally ill women. Cancer 118(1):27–37.Crossref, Google Scholar
• Lederle FA, Johnson GR, Wilson SE, Littooy FN, Krupski WC, Bandyk D, Acher CW, et al. (2000) Yield of repeated screening for abdominal aortic aneurysm after a 4-year interval. Arch. Internal Medicine 160(8):1117–1121.Crossref, Google Scholar
• Lee E, Lavieri MS, Volk M (2019) Optimal screening for hepatocellular carcinoma: A restless bandit model. Manufacturing Service Oper. Management 21(1):198–212.Link, Google Scholar
• Liao S, Li J, Wei W, Wang L, Zhang Y, Li J, Wang C, Sun S (2011) Association between diabetes mellitus and breast cancer risk: A meta-analysis of the literature. Asian Pacific J. Cancer Prevention 12(4):1061–1065.Google Scholar
• Lipscombe LL, Hux JE, Booth GL (2005) Reduced screening mammography among women with diabetes. Arch. Internal Medicine 165(18):2090–2095.Crossref, Google Scholar
• Maillart LM, Ivy JS, Ransom S, Diehl K (2008) Assessing dynamic breast cancer screening policies. Oper. Res. 56(6):1411–1427.Link, Google Scholar
• Mandelblatt JS, Wheat ME, Monane M, Moshief RD, Hollenberg JP, Tang J (1992) Breast cancer screening for elderly women with and without comorbid conditions: A decision analysis model. Ann. Internal Medicine 116(9):722–730.Crossref, Google Scholar
• Mandelblatt JS, Cronin KA, Bailey S, Berry DA, De Koning HJ, Draisma G, Huang H, et al. (2009) Effects of mammography screening under different screening schedules: Model estimates of potential benefits and harms. Ann. Internal Medicine 151(10):738–747.Crossref, Google Scholar
• Mandelblatt JS, Near AM, Miglioretti DL, Munoz D, Sprague BL, Trentham-Dietz A, Gangnon R, et al. (2018) Common model inputs used in CISNET collaborative breast cancer modeling. Medical Decision Making 38(1 suppl):9S–23S.Crossref, Google Scholar
• Mandelblatt JS, Stout NK, Schechter CB, Van Den Broek JJ, Miglioretti DL, Krapcho M, Trentham-Dietz A, et al. (2016) Collaborative modeling of the benefits and harms associated with different US breast cancer screening strategies. Ann. Internal Medicine 164(4):215–225.Crossref, Google Scholar
• Martin ET, Kaye KS, Knott C, Nguyen H, Santarossa M, Evans R, Bertran E, Jaber L (2016) Diabetes and risk of surgical site infection: A systematic review and meta-analysis. Infection Control Hospital Epidemiology 37(1):88–99.Crossref, Google Scholar
• May DS, Kiefe CI, Funkhouser E, Fouad MN (1999) Compliance with mammography guidelines: Physician recommendation and patient adherence. Preventative Medicine 28(4):386–394.Crossref, Google Scholar
• Mayo Clinic (2018) Menopause. Accessed August 19, 2018, https://www.mayoclinic.org/diseases-conditions/menopause/symptoms-causes/syc-20353397.Google Scholar
• Monahan GE (1982) State of the art—A survey of partially observable Markov decision processes: Theory, models, and algorithms. Management Sci. 28(1):1–16.Link, Google Scholar
• NIDDK (2018) The A1C test and diabetes. Accessed May 17, 2018, https://www.niddk.nih.gov/health-information/diabetes/diagnosis-diabetes-prediabetes/a1c-test.Google Scholar
• NIH (2017) Menopausal. Accessed February 14, 2019, http://www.nia.nih.gov/health/publication/menopause. (Accessed on 2019-02-14).Google Scholar
• Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, et al. (2018) National Cancer Institute, SEER cancer statistics review, 1975-2015. https://seer.cancer.gov.Google Scholar
• Parekh AK, Goodman RA, Gordon C, Koh HK, HHS Interagency Workgroup on Multiple Chronic Conditions (2011) Managing multiple chronic conditions: A strategic framework for improving health outcomes and quality of life. Public Health Rep. 126(4):460–471.Crossref, Google Scholar
• Pliskin JS, Shepard DS, Weinstein MC (1980) Utility functions for life years and health status. Oper. Res. 28(1):206–224.Link, Google Scholar
• Pradhan AD, Rifai N, Buring JE, Ridker PM (2007) Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. Amer. J. Medicine 120(8):720–727.Crossref, Google Scholar
• PRC (2014) Global population estimates by age, 1950-2050. Accessed June 1, 2018, https://www.pewresearch.org/global/2014/01/30/global-population/.Google Scholar
• Presson AP, Partyka G, Jensen KM, Devine OJ, Rasmussen SA, McCabe LL, McCabe ER (2013) Current estimate of down syndrome population prevalence in the united states. J. Pediatrics 163(4):1163–1168.Crossref, Google Scholar
• Reinier KS, Vacek PM, Geller BM (2007) Risk factors for breast carcinoma in situ vs. invasive breast cancer in a prospective study of pre-and post-menopausal women. Breast Cancer Res. Treatment 103(3):343–348.Crossref, Google Scholar
• Ronco AL, Stefani ED, Deneo-Pellegrini H, Quarneti A (2012) Diabetes, overweight and risk of postmenopausal breast cancer: A case-control study in Uruguay. Asian Pacific J. Cancer Prevention 13(1):139–146.Crossref, Google Scholar
• Salisbury C (2012) Multimorbidity: Redesigning healthcare for people who use it. Lancet 380(9836):7–9.Crossref, Google Scholar
• Saydah SH, Loria CM, Eberhardt MS, Brancati FL (2001) Subclinical states of glucose intolerance and risk of death in the US. Diabetes Care 24(3):447–453.Crossref, Google Scholar
• Schoen RE, Marcus M, Braham RL (1994) Factors associated with the use of screening mammography in a primary care setting. J. Community Health 19(4):239–252.Crossref, Google Scholar
• Selvin E, Steffes MW, Gregg E, Brancati FL, Coresh J (2011) Performance of a1c for the classification and prediction of diabetes. Diabetes Care 34(1):84–89.Crossref, Google Scholar
• Smallwood RD, Sondik EJ (1973) The optimal control of partially observable Markov processes over a finite horizon. Oper. Res. 21(5):1071–1088.Link, Google Scholar
• Stentz FB, Brewer A, Wan J, Garber C, Daniels B, Sands C, Kitabchi AE (2016) Remission of pre-diabetes to normal glucose tolerance in obese adults with high protein vs. high carbohydrate diet: Randomized control trial. BMJ Open Diabetes Res. Care 4(1):e000258.Crossref, Google Scholar
• Taksler GB, Keshner M, Fagerlin A, Hajizadeh N, Braithwaite RS (2013) Personalized estimates of benefit from preventive care guidelines: A proof of concept. Ann. Internal Medicine 159(3):161–168.Crossref, Google Scholar
• Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D (2005) Comorbidity and survival disparities among black and white patients with breast cancer. JAMA 294(14):1765–1772.Crossref, Google Scholar
• Uhlig K, Leff B, Kent D, Dy S, Brunnhuber K, Burgers JS, Greenfield S, et al. (2014) A framework for crafting clinical practice guidelines that are relevant to the care and management of people with multimorbidity. J. General Internal Medicine 29(4):670–679.Crossref, Google Scholar
• USPSTF (2016) Breast cancer: Screening. Accessed September 23, 2018, https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening.Google Scholar
• Vaeth PA, Satariano WA, Ragland DR (2000) Limiting comorbid conditions and breast cancer stage at diagnosis. J. Gerontology Series A Biology Sci. Medical Sci. 55(10):M593–M600.Crossref, Google Scholar
• Velanovich V (1995) Immediate biopsy vs. observation for abnormal findings on mammograms: An analysis of potential outcomes and costs. Amer. J. Surgery 170(4):327–332.Crossref, Google Scholar
• Walter LC, Covinsky KE (2001) Cancer screening in elderly patients: A framework for individualized decision making. JAMA 285(21):2750–2756.Crossref, Google Scholar
• Walter LC, Lindquist K, Nugent S, Schult T, Lee SJ, Casadei MA, Partin MR (2009) Impact of age and comorbidity on colorectal cancer screening among older veterans. Ann. Internal Medicine 150(7):465–473.Crossref, Google Scholar
• Wang Z-H, Fang J-Y (2014) Colorectal cancer in inflammatory bowel disease: Epidemiology, pathogenesis and surveillance. Gastrointestinal Tumors 1(3):146–154.Crossref, Google Scholar
• WHO (2016) Global report on diabetes. Technical report, World Health Organization, Geneva, Switzerland.Google Scholar
• WHO (2017) Noncommunicable diseases progress monitor. Technical report, World Health Organization, Geneva, Switzerland.Google Scholar
• WHO (2019) Breast cancer. Accessed March 10, 2019, https://www.who.int/news-room/fact-sheets/detail/breast-cancer.Google Scholar
• Xue F, Michels KB (2007) Diabetes, metabolic syndrome, and breast cancer: A review of the current evidence. Amer. J. Clinical Nutrition 86(3):823S–835S. Crossref, Google Scholar
• Zhang S, Ivy JS, Payton FC, Diehl KM (2010) Modeling the impact of comorbidity on breast cancer patient outcomes. Health Care Management Sci. 13(2):137–154.Crossref, Google Scholar
• Zhang J, Denton BT, Balasubramanian H, Shah ND, Inman BA (2012) Optimization of PSA screening policies: A comparison of the patient and societal perspectives. Medical Decision Making 32(2):337–349.Crossref, Google Scholar
• Zhou H, Isaman DJ, Messinger S, Brown MB, Klein R, Brandle M, Herman WH (2005) A computer simulation model of diabetes progression, quality of life, and cost. Diabetes Care 28(12):2856–2863.Crossref, Google Scholar